factor

(redirected from factor VII)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to factor VII: factor VIII, factor IX, factor XII

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
Perzborn, Potential of activated prothrombin complex concentrate and activated factor VII to reverse the anticoagulant effects of rivaroxaban in primates, Practice., 2, 3 (2008).
The Australian and New Zealand Haemostasis Registery: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus 2015; 13: 86-101.
Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII. Clin Appl Thrombosis/Hemostasis.
Inherited factor VII deficiency is a rare congenital coagulation disorder with autosomal recessive inheritance.
(14) found that pollutants less than 10 PM in size can increase platelet and Factor VII levels.
The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.
Firstly, the most important mechanism for coagulation activation in vivo is the interaction between circulating factor VII and tissue factor (2), which is present in subendothelial tissue and exposed to plasma when vascular damage occurs.
Experiments with blood plasma reveal that the gel kicks into gear a blood-clotting protein known as factor VII, a key player in the cascade of events leading to coagulation, said biomedical engineer Brendan Casey of the University of Maryland in College Park.
Recombinant activated factor VII, made from cloned baby hamster kidney cells (Welsby, Monroe, Lawson, & Hoffinan, 2005), is variously referred to in the literature as factor VII, rFVIIa, rFVII, FVIIa, or activated factor VII.